Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-42.27%
0%
-42.27%
6 Months
-86.11%
0%
-86.11%
1 Year
-90.9%
0%
-90.9%
2 Years
-94.72%
0%
-94.72%
3 Years
-97.3%
0%
-97.3%
4 Years
-98.24%
0%
-98.24%
5 Years
-97.88%
0%
-97.88%
BBS-Bioactive Bone Substitutes Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-192.65%
EBIT to Interest (avg)
-1.89
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.05
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.61%
ROE (avg)
3.48%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.40
EV to EBIT
-1.63
EV to EBITDA
-1.74
EV to Capital Employed
0.71
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-43.42%
ROE (Latest)
-81.51%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bearish
Shareholding Snapshot : Jun 2023
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (1.23%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-3.10
-2.70
-14.81%
Interest
0.10
0.10
Exceptional Items
0.00
0.00
Consolidate Net Profit
-3.50
-3.10
-12.90%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 0.00% vs 0.00% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -12.90% vs -10.71% in Dec 2022
About BBS-Bioactive Bone Substitutes Plc 
BBS-Bioactive Bone Substitutes Plc
Medical Specialties
BBS-Bioactive Bone Substitutes Oyj (BBS) is a Finland-based company engaged in the medical equipment industry. The Company operates as a biotechnology company that develops and distributes medical device implants used in orthopedic surgery. Its products include ARTEBONE, an orthopedic bone substitute material made from reindeer bone protein matrix made using a propriety patented manufacturing process that can be used in various application areas, such as bone regeneration, healing of fractures, non-unions, bone defect, dental implantation, orthopedics, maxillofacial/dental surgery and osteoporotic fractures.
Company Coordinates 
Company Details
Kiviharjunlenkki 6 , OULU None : 90220
Registrar Details






